Ulcer Foot Clinical Trials

12 recruiting

Ulcer Foot Trials at a Glance

12 actively recruiting trials for ulcer foot are listed on ClinicalTrialsFinder across 6 cities in 3 countries. The largest study group is Not Applicable with 6 trials, with the heaviest enrollment activity in Monroeville, Philidelphia, and Düsseldorf. Lead sponsors running ulcer foot studies include Applied Biologics, LLC, BioLab Holdings, and Axolotl Biologix.

Browse ulcer foot trials by phase

Treatments under study

About Ulcer Foot Clinical Trials

Looking for clinical trials for Ulcer Foot? There are currently 12 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Ulcer Foot trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Ulcer Foot clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting
Not Applicable

Modified Platform Trial Assessing Multiple CAMPs and SOC vs SOC Alone in the Treatment of Hard-to-Heal DFUs

Diabetic FootFoot UlcerUlcer Foot+1 more
StimLabs272 enrolled5 locationsNCT06449638
Recruiting
Phase 4

A Multicenter, Prospective, Controlled Clinical Trial Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers

Diabetic Foot UlcerDiabetic FootFoot Ulcer Due to Type 2 Diabetes Mellitus+4 more
Applied Biologics, LLC60 enrolled1 locationNCT07159282
Recruiting
Phase 4

A Multicenter, Prospective, Controlled Modified Multi-Platform Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers.

Venous UlcerDiabetic Foot UlcerUlcer+6 more
BioLab Holdings50 enrolled1 locationNCT07364630
Recruiting
Not Applicable

Early Percutaneous Transluminal Angioplasty in Diabetic Foot Syndrome (PTA-DFS)

Diabetes MellitusPeripheral Arterial DiseaseAnemia+6 more
Heinrich-Heine University, Duesseldorf200 enrolled1 locationNCT06124586
Recruiting
Phase 3

The Prospective, Double-blind, Multicenter, Placebo-controlled, Randomized, Comparative Clinical Trial

Ulcer FootMellitus Diabetes
JSC NextGen144 enrolled1 locationNCT07391319
Recruiting
Not Applicable

Total Contact Soft Cast in Diabetic Foot Ulcers

Diabetes MellitusDiabetic Foot UlcerFoot Ulcer, Diabetic+5 more
University of Minnesota100 enrolled1 locationNCT04210089
Recruiting
Phase 4

Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers

Diabetic Foot UlcerDiabetic FootFoot Ulcer, Diabetic+6 more
BioLab Holdings650 enrolled1 locationNCT07089602
Recruiting
Phase 4

Randomized Evaluation of Nonhealing Diabetic Foot Ulcers With Exclusive Wound Therapy

Diabetic Foot UlcerFoot Ulcer Due to Type 2 Diabetes MellitusUlcer+4 more
Sequence LifeScience, Inc.350 enrolled1 locationNCT07086443
Recruiting
Phase 4

Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers.

Diabetic Foot UlcerDiabetic FootFoot Ulcer, Diabetic+6 more
Tiger Biosciences, LLC.340 enrolled1 locationNCT06826339
Recruiting
Not Applicable

Dehydrated Human Amnion Membrane and Standard of Care Versus Standard of Care Alone in Nonhealing Diabetic Foot Ulcers

Diabetic Foot UlcerDiabetic FootFoot Ulcer+1 more
Axolotl Biologix100 enrolled1 locationNCT06550596
Recruiting
Not Applicable

Modified Multi-Platform Trial Assessing Multiple CAMPs and SOC vs SOC Alone in the Treatment of DFU and VLUs

Diabetic Foot UlcerLeg UlcerUlcer Foot+1 more
Stability Biologics324 enrolled1 locationNCT06560502
Recruiting
Not Applicable

Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care Versus Standard of Care

Diabetic Foot UlcerDiabetic FootFoot Ulcer+2 more
Applied Biologics, LLC124 enrolled1 locationNCT06564831